Mathew Pombo, MD
Sports Medicine · Duluth, GANPI 1346413648
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,300 of the $13,319 with a category attached, or 77.3%. Stryker accounts for 79.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $10,384 and has fallen 78.6% since, to $2,222 in 2025.
Across 36 payments — averaging $369.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$11K
- Newclip USA LLC$2K
- Johnson & Johnson$222
- Smith+Nephew$209
- Bioventus LLC$125
- Vertex$62
- plus $161 from 6 others
Across 41 payments — averaging $18,332 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$565K
- Miach Orthopaedics, Inc.$177K
- Geistlich Pharma, North America, Inc.$9K
What the payments were for
- Consulting fees$10,30077%
- Travel & lodging$1,79513%
- Food & beverage$1,2249%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 16 | $10,607 |
| Newclip USA LLC | 2 | $1,933 |
| Johnson & Johnson | 4 | $222 |
| Smith+Nephew | 3 | $209 |
| Bioventus LLC | 1 | $125 |
| Vertex | 2 | $62 |
| Ferring Pharmaceuticals Inc. | 2 | $51 |
| Pacira Pharmaceuticals Incorporated | 2 | $40 |
| Vericel Corporation | 1 | $22 |
| Moximed, Inc | 1 | $16 |
| Anika Therapeutics, Inc. | 1 | $16 |
| Biotronik NRO, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,319 in reported general payments places this provider in the 80th percentile of 168 sports medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 14 | $231 |
| Meloxicam | 41 | $167 |
| Cyclobenzaprine Hcl | 17 | $80 |
| Tramadol Hcl | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Duluth
- Timothy MaughonDuluth$14K
- John XerogeanesAtlanta$4M
- Joseph BurnsAlpharetta$376K
- Sameh LabibBrookhaven$280K
- Spero KarasAtlanta$137K
- Xavier DuraldeAtlanta$77K
- Thomas MyersAtlanta$72K
- Robert O'ConnellCarrollton$69K
- Elan GolanSnellville$57K
- Taylor PolanderJesup$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.